Birmingham, Alabama
Division Director Vascular Surgery and Endovascular Therapy
University of Alabama at Birmingham
Professor of Surgery
UAB Medicine
SCHEDULE FOR VEITHsymposium™
Wednesday, November 17, 2021
Presenter
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
Transcaval Access To AAA Sacs For Treatment Of Type 2 Endoleaks After EVAR: When And How To Do It
10:34 AM - 10:39 AM
Presenter
SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; ETHICS OF INSURANCE; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES, ENDPOINTS; INDUSTRY RELATIONS; IMPACT OF GOVERNMENT (ACA) AND REGULATORY AGENCIES (FDA)
Update On Valuable New Information From The International Consortium of Vascular Registries (ICVR)
4:25 PM - 4:30 PM
Thursday, November 18, 2021
Presenter
SESSION 49: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAS AND TAAAS; AND RELATED TOPICS
DEBATE: The Case Against Ch/EVAR And Parallel Grafts For Complex AAA And TAAA Repairs: F/B/EVAR Is Much Better
9:56 AM - 10:01 AM
Friday, November 19, 2021
Presenter
SESSION 79: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
SCI Is More Severe And Resolves Less When Routine CSF Drainage Is Used With TAAA Repairs: When Should It Be Used Selectively And With What Precautions
7:10 AM - 7:15 AM
Presenter
SESSION 93: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
Value Of Statins In AAA Patients After Repair: Long-Term Impact On Mortality
3:06 PM - 3:11 PM
 
previous next